## 

## 

|**Page:**||
|---|---|
|2|Reference and administrative details|
|3|Chairman's report|
|4|Trustees' report (incorporating the Strategic Report)|
|24|Independent auditor's report|
|27|Consolidated statement of financial activities|
|`28`|Group and Charity balance sheets|
|30|Consolidated cash flow statement|
|31|Notes to the cash flow statement|
|`32`|Notes forming part of the financial statements|





## 

## 

## 

## 

## 



## 



## 

## 

## 



## 

## 










## 

## 

|**Age Category**|**Patients Cared For**|
|---|---|
|Under18|11|
|18-25|22|
|Over 25|7|
|**Grand Total**|**`40`**|





## 



## 



## 



## 





## 



## 



## 

|**inancial Review**|||||
|---|---|---|---|---|
||**Income**|**Expenditure**|**Contribution**|**2021**|
||(£OOO's)|(£000's)|(£000's)|(£00O's)|
|**Cost of delivering hospice services**||8,159|(8,159)|(7,883)|
|**This cost is funding by the following sources:**|||||
|Grants|6,821|o|6,821|7,335|
|Fundraising|1,766|930|836|865|
|Legacies|9,727||9,727|2,405|
|Lottery|452|184|268|283|
|Trading|4,156|4,161|(5)|(459)|
|Investment Income|202|38|164|170|
|Gains/Losses invalue ofinvestments|113|o|113|965|
|OtherIncome|116|116|o|(430)|
|**Total Contribution**|23,353|5,429|17,924|11,134|
|**Net Surplus**|||9,765|3,251|



## 

## 

## 

## 

## 



## 

## 


## 



## 

## 

|Mrs Irene Argent|Mrs Jessica Arthur|Mrs Carol Ann Baker|Mrs Pamela Blatchley|
|---|---|---|---|
|Mrs Sheila Bugg|Mr Ian Bunting|Mrs Dorothy Burch|Mrs Patricia Burrage|
|Mrs Kathleen Clarke|Mr Bryan Clow|Mrs Joan Crane|Ms Mary Cresswell|
|Miss Margaret Curwen|Mrs Joyce Dumper|Mrs Rosemary Farrand|Mrs Ruth Felton|
|Mr Peter Grimwade|Mrs Muriel Hazard|Mr Eric Holton|Mr Roy Hubbard|
|Mrs Janet Jackaman|Mrs Winifred Jacobs|Mr Paul King|Mr John Lankester|
|Mrs Alexis Maddison|Mrs Patricia Marshall|Mrs Jacqueline May|Mrs Jean May|
|Mrs Elizabeth Moore|Mr Wylie Moore|Reverend Ian Morgan|Mr David Murphy|
|Mr Russell Parker|Ms Peggy Parker|Mrs Christine Pickering|Mrs Vivienne Quayle|
|Mr Laurie Rand|Miss Daphne Randle|Mr Raymond Rix|Mrs Hilda Rogers|
|Mr John Sadd|Mr David Seager|Mr Robert Seaman|Mrs Joyce Shaw|
|Lady Mary Sinclair|Mrs Eileen Stansfield|Ms Enid Stimpson|Mrs Sheila Thomas|
|Mr John Ware|Mrs **M** Waterhouse|Mr David Whittaker|Mr John Wilkinson|
|Mrs Alexander Wood|Miss Isobel Yonge|||



## 



## 

## 

|**Designated Fund**|||**Change**||**Amount**|
|---|---|---|---|---|---|
|**Building Refurbishment**||||||
|Provision for office refurbishments to allow for updating of||the parts of the|Increased from £500,000||£3,500,000|
|Hospice most<br>in<br>need<br>of updating and to create some|flexible space to||at March 2021|||
|accommodate more modern methods ofworking.||||||
|**Patient Services Projects**||||||
|A number of planned investments in future patient services||where statutory|Increased from £1,065,000||£2,420,000|
|funding<br>is not available. (Incorporates the Young Adults Project separately|||at March 2021.|||
|identified as a designated fund at March 2021)||||||
|**Energy Efficiency** & **Carbon Neutral Investment**||||||
|The Hospice recognizes investment is needed to ensure that the Hospice is|||Newly created||£500,000|
|energy efficient and actively contributes to the reduction in carbon emissions|||designated fund|||
|**Anticipated Future Deficits 2022-25**||||||
|The Hospice does not anticipated operating at a breakeven position over the|||Newly created||£1,700.,000|
|next 3 years due to inflationary and service pressures.|||designated fund|||
|It is assumed that a reserve will therefore need to make up this shortfall as the||||||
|Hospice works to move back into annual financial balance.||||||
|**Legacy Deferral**||||||
|In addition to the above Anticipated Future Deficitfund, Trustees have agreed|||Additional legacy added||£1,177,000|
|to spread recognition of larger legacies over four financial|years for financial||and the release ofthe|||
|planning purposes, so that the volatile<br>nature of<br>legacies||income can be|second year of legacies|||
|smoothed. Based on three legacies notified in 2020/21 and|2021/22, there will||previously designated|||
|be £1.177million deferred for release over the next 3 years.||||||
|**Major Legacy Received in 2022**||||||
|The Hospice was notified of a significant legacy, which|is|expected to be|Newly created||£7,650,000|
|received in 2022/23. Accounting rules mean thatthis needs to be recognised|||designated fund|||
|as income in 2021/22 since the amount can be reasonably||estimated.<br>The||||
|Trustees are now beginning discussions on how this significant investment||||||
|can be used to improve and expand services provided by the||Hospice||||
|**Retail Lockdown fund**||||||
|This fund was established during the pandemic to offset potential losses from|||Discontinue as a||£0|
|the adverse impact on the Hospice's retail activities.<br>It is now deemed not to|||designated fund at March|||
|be required.|||2022|||
|**Out of Hospital Project with ESNEFT**||||||
|The Hospital has agreed to expand its outofhospital services||through working|Newly created||£690,000|
|with ESNEFT.<br>This three-year project will begin<br>in 2022.||Each party has|designated fund|||
|committed £690,000 to the project, creating a projectwith a|combined budget|||||
|of£1.38m||||||
|**Total Designated Funds**||||**£17,637,000**||
|t 31 March 2022 the Group's reserves were as follows.||||||
|||||**2022**|**2021**|
|||||£000|£000|
|**Restricted Funds**||||**166**|**253**|
|**Designated Funds**||||||
|Fixed Asset Fund||||5,413|5,870|
|Building refurbishment fund||||3,500|500|
|Patient services fund||||2,420|1,000|
|Energy efficiency & carbon neutral investment||||500||
|Anticipated future deficits 2022-25||||1,700||
|Legacies deferral||||1,177|1,012|
|Major Legacy Received in 2022||||7,650||
|Retail lockdown|||||550|
|Out of Hospital Project with ESNEFT||||690||
|Service Development Fund _(now consolidated into Patient Services fund)_|||||65|
|**Total Designated Funds**||||**23,050**|**8,997**|
|**General fund**||||**2,994**|**7,195**|





## 

## 

## 



## 

## 

## 

## 



## 

## 

## 



## 

## 

## 

## 

||**Board of**|**Finance**&|**Governance**|**Income**|**Care &**|**People**&|
|---|---|---|---|---|---|---|
||**Trustees**|**Investment**|& **Oversight**|**Generation** &|**Clinical**|**Culture**|
|||||**Comms**|**Governance**||
|Nick Banks|8/8||||||
|William Barnes|8/8||||||
|Pam Fenner|5/8||||||
|Nick Hatton|5/8||||||
|Ann Hogarth|8/8||||||
|Terry Hunt|7/8||||||
|Graham Mackenzie|5/8||||||
|Anthony Nicholl|7/8||||||
|Ann (Nina) Parkinson|5/8||||||
|Ian Turner|8/8||||||
|**Resigned Trustees**|||||||
|Grainne Drummond|1/2||||||
|Mark Nicholls|1/6||||||
|**New Trustees**|||||||
|John Pickering|2/3||||||





## 

## 

## 

## 

## 



## 

## 

## 



## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 



## 

|||**Unrestricted**|**Restricted**||Unrestricted|Restricted||
|---|---|---|---|---|---|---|---|
|||**Funds**|**Funds**|**2022**|Funds|Funds|2021|
|||£|£|£|£|£|£|
|**Income from donations, legacies**||||||||
|**and grants**|**5**|**11,352,640**|**140,790**|**11,493,430**|4,050,797|147,257|4,198,054|
|**Income from charitable activities**|**6**|**5,106,811**|**1,714,261**|**6,821,072**|4,493,613|2,841,853|7,335,466|
|**Income from trading activities**||||||||
|Commercial trading||**4,084,717**||**4,084,717**|1,715,520||1,715,520|
|Lottery subscriptions||**452,484**||**452,484**|477,080||477,080|
|Other income||**71,085**||**71,085**|55,350||55,350|
|||**4,608,286**||**4,608,286**|2,247,950||2,247,950|
|**Investment income**|7|**201,981**||**201,981**|205,650||205,650|
|**Other Income**||**115,946**||**115,946**|894,809||894,809|
|**Total income**||**21,385,664**|**1,855,051**|**23,240,715**|11,892,819|2,989,110|14,881,929|
|**Expenditure on:**|**8**|**5,421,867**|**7,505**|**5,429,372**|4,712,997||4,712,997|
|**Raising funds**||||||||
|**Charitable activities:**|**8**|**6,224,521**|**1,934,410**|**8,158,931**|5,064,396|2,818,274|7,882,670|
|**Total expenditure**|**8**|**11,646,388**|**1,941,915**|**13,588,303**|9,777,393|2,818,274|12,595,667|
|**Net income from operational activities**||**9,739,276**|**(86,864)**|**9,652,412**|2,115,426|170,836|2,286,262|
|**Net gains/ (losses) on investments**|**11**|**113,186**||**113,186**|965,372||965,372|
|**Net movement** in **funds before**||||||||
|**transfers**||**9,852,462**|**(86,864)**|**9,765,598**|3,080,798|170,836|3,251,634|
|Transfers|**17**|||||||
|**Net movement in funds after transfers**||**9,852,462**|**(86,864)**|**9,765,598**|3,080,798|170,836|3,251,634|
|**Reconciliation of funds**||||||||
|Fund balances broughtforward||**16,192,340**|**252,645**|**16,444,985**|13,111,542|81,809|13,193,351|
|Fund balancescarried forward|17|**26,044,802**|**165,781**|**26,210,583**|16,192,340|252,645|16,444,985|





## 

## 

|||**Group**|**Group**|**Charity**|**Charity**|
|---|---|---|---|---|---|
|||**2022**|2021|**2022**|2021|
||**Note**|£|£|£|£|
|**Fixed assets**||||||
|Tangible assets|**10.1**|**5,311,241**|5,723,990|**5,297,453**|5,723,990|
|Intangible assets|**10.2**|**102,257**|146,615|**102,257**|146,615|
|Investments|**11**|**6,156,108**|5,537,351|**6,186,108**|5,567,351|
|||**11,569,606**|11,407,956|**11,585,818**|11,437,956|
|**Current assets**||||||
|Stocks|**13**|**91,792**|72,611|**5,760**|6,554|
|Debtors|**14**|**12,117,858**|2,616,164|**12,273,671**|2,636,218|
|Cash at bank and in hand|**15**|**7,663,953**|4,397,247|**7,649,593**|4,395,388|
|||**19,873,603**|7,086,022|**19,929,024**|7,038,160|
|**Creditors: amounts falling due**||||||
|**within one year**|**16**|**5,200,804**|2,048,993|**5,154,389**|1,978,852|
|**Net current assets**||**14,672,799**|5,037,029|**14,774,635**|5,059,308|
|**Provisions for liabilities**|**16.1**|**31,822**||**31,822**||
|**Net assets**||**26,210,583**|16,444,985|**26,328,631**|16,497,264|
|**General fund (unrestricted)**||**2,994,304**|7,194,851|**3,126,140**|7,247,130|
|**Designated funds (unrestricted)**||||||
|Fixed assets fund||**5,413,498**|5,870,605|**5,399,710**|5,870,605|
|Building refurbishmentfund||**3,500,000**|500,000|**3,500,000**|500,000|
|Patient services projects fund||**2,420,000**|1,064,884|**2,420,000**|1,064,884|
|Future deficit offset||**1,700,000**||**1,700,000**||
|Legacies deferralfund||**1,177,000**|1,012,000|**1,177,000**|1,012,000|
|Major legacy received in 2022||**7,650,000**||**7,650,000**||
|Out ofhospital projectwith ESNEFT||**690,000**||**690,000**||
|Energy efficiency and carbon neutral||**500,000**||**500,000**||
|investments||||||
|Retail lockdown fund|||550,000||550,000|
|**Restricted funds**||**165,781**|252,645|**165,781**|252,645|
|**Total funds**|**17**|**26,210,583**|16,444,985|**26,328,631**|16,497,264|








## 

||**Note**|**2022**|2021|
|---|---|---|---|
|||£|£|
|**Net cash generated by/(used in) operating**|A|||
|**activities**||**3,816,472**|2,749,054|
|**Cashflows from investing activities**||||
|Interest received||**549**|1,700|
|Income from fixed asset investments||**201,431**|203,950|
|Purchase of tangible fixed assets||**(184,341)**|(90,787)|
|Purchase of intangible fixed assets||**(25,834)**|(43,842)|
|Purchase of goodwill||**(36,000)**||
|Decrease/ (Increase) in investment cash||**(11)**|12,855|
|Proceeds from sale of fixed asset investments||||
|Purchase of fixed asset investments||**(505,560)**|(16,310)|
|Net cash provided by investing activities||**(549,766)**|67,566|
|**Change in cash and cash equivalents in the**|B|||
|**reporting period**||**3,266,706**|2,816,620|
|Cash and cash equivalents at the beginning of the||||
|reporting period||**4,397,247**|1,580,627|
|**Cash and cash equivalents at the end of the**||||
|**reporting period**||**7,663,953**|4,397,247|





## 

|||**2022**|2021|
|---|---|---|---|
|||£|£|
||Net expenditure forthe reporting period|**9,652,413**|2,286,262|
||Investment income|**(201,981)**|(205,650)|
||Depreciation, amortisation and loss on disposal|**667,283**|401,105|
||Impairmentofgoodwill|**36,000**||
||(lncrease)/decrease in stocks|**(19,181)**|13,734|
||(Increase)/decrease in debtors|**(9,501,694)**|(616,032)|
||(Decrease)/increase in creditors|**3,183,632**|869,635|
||**Net cash generated by/(used in) operating activities**|**3,816,472**|2,749,054|
|**B **|**Analysis of changes in net funds**|||
|||**2022**|2021|
|||£|£|
||**Operating net funds**|||
||Cash and cash equivalents|**4,397,247**|1,580,627|
||Changes in netfunds arising from:|||
||Cashflows ofthe entity|**3,266,706**|2,816,620|
||**Closing net funds**|||
||Cash and cash equivalents|**7,663,953**|4,397,247|





## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

|**movement in funds**|||
|---|---|---|
||**2022**|2021|
||£|£|
|This has been arrived at after charging:|||
|Depreciation|**597,091**|361,761|
|Amortisation|**33,642**|13,913|
|Impairment of goodwill|**36,000**||
|Loss on disposal of fixed assets||25,431|
|Government grants - Coronavirus Job Retention Scheme|**4,214**|635,151|
|Government grants - Business Rates Relief|**105,531**|259,656|
|Government Grants-Workforce Retention Grant|**6,200**||
|Operating lease payments - equipment|**34,594**|33,826|
|Operating lease payments - land and buildings|**489,840**|409,613|
|Auditor's remuneration - charity|**17,950**|17,875|
|Auditor's remuneration - subsidiaries|**7,150**|6,500|
|Auditor's remuneration- corporation tax fees|**4,450**|3,817|
|Auditor's remuneration- other|**1,450**|1,349|





## 

|**f costs**|||
|---|---|---|
||**2022**|2021|
||£|£|
|Salaries|**8,817,642**|8,606,836|
|Social security costs|**738,197**|719,222|
|Pension costs|**647,121**|616,314|
||**10,202,960**|9,942,372|



|e yearwas as follows:|||
|---|---|---|
||**2022**|2021|
||**Number**|Number|
|£60,001 -£70,000|**3**|4|
|£70,001 -£80,000|**3**|2|
|£80,000 - £90,000|**4**|1|
|£90,001 - £100,000|**1**|1|
|£100,000 -£110,000||2|
|£130,001 -£140,000||1|
|£140,001 -£150,000|**1**||
||**12**|11|



||**2022**|2021|
|---|---|---|
||**Full time**|Full time|
||**equivalent**|equivalent|
|Hospice services|**143**|142|
|Fundraising and publicity|**19**|21|
|Shops|**64**|59|
|Management and administration|**53**|47|
||**279**|269|





## 

## 

|**5**|**Income from donations and legacies**||||||
|---|---|---|---|---|---|---|
|||||**2022**||2021|
||**Unrestricted income:**||£|£|£|£|
||In memoriam|||**470,385**||497,816|
||Trusts|||**302,957**||183,170|
||Fundraising donations and other gifts|||**851,857**||964,844|
|||||**1,625,199**||1,645,830|
||**Restricted income:**||||||
||In memoriam||**10,540**||||
||Trusts||**106,234**||60,469||
||Fundraising donations and other gifts||**24,016**||86,788||
|||||**140,790**||147,257|
|||||**1,765,989**||1,793,087|
||Legacies-unrestricted|**9,727,441**|||2,404,967||
||Legacies-restricted||||||
|||||**9,727,441**||2,404,967|
|||||**11,493,430**||4,198,054|
|**6**|**Income from charitable activities**||||||
||||||**2022**|2021|
||||||£|£|
||Unrestricted income: Grants (Ipswich & East Suffolk||CCG)||**2,600,066**|2,180,366|
||Unrestricted income: Grants (GreatYarmouth & Waveney CCG)||||**1,662,120**|1,440,531|
||Unrestricted income: CCG COVID-19 related|Grant|||**844,625**|872,716|
||Restricted income: NHS England grant||||**1,677,421**|2,642,892|
||Restricted income: Grants||||**36,840**|198,961|
||||||**6,821,072**|7,335,466|



||**2022**|2021|
|---|---|---|
||£|£|
|Bank deposit and building society interest|**550**|1,700|
|Interest and dividends on listed investments|**201,431**|203,950|
||**201,981**|205,650|





## 

|**8**|**Analysis of expenditure**|||
|---|---|---|---|
||**Costs of raising funds**|**2022**|2021|
||_Fundraising_|£|£|
||Fundraising expenses|**631,265**|641,613|
||Support costs|**298,800**|286,251|
|||**930,065**|927,864|
||_Commercial trading_|||
||Trading costs|**3,293,371**|2,743,353|
||Support costs|**983,038**|811,859|
|||**4,276,409**|3,555,212|
||_Lottery prizes and administration_|||
||Prizes and administration|**162,819**|175,727|
||Support costs|**21,660**|18,656|
|||**184,479**|194,383|
||_Investment management costs_|**38,419**|35,538|
||**Total Costs of raising funds**|**5,429,372**|4,712,997|
||**Costs of charitable activities**|||
||_Inpatient Unit_|||
||Patient care|**2,649,206**|2,985,498|
||Catering|**174,841**|204,516|
||Support costs|**628,840**|614,761|
|||**3,452,887**|3,804,775|
||_Day Services_|||
||Patient care|**424,034**|279,251|
||Support costs|**58,870**|94,025|
|||**482,904**|373,276|
||_Community_|||
||Patient care|**2,378,734**|2,221,532|
||Support costs|**732,902**|573,625|
|||**3,111,636**|2,795,157|
||_Therapies and Wellbeing_|||
||Patient care|**792,363**|687,436|
||Support costs|**319,141**|222,026|
|||**1,111,504**|909,462|
||**Total costs of charitable activities**|**8,158,931**|7,882,670|
||**Total expenditure**|**13,588,303**|12,595,667|





## 

|**9**|**Support costs **|**allocation**|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|||Finance &|Office|IT|HR|Property&|PR|Education|**2022**|2021|
|||**legal**|**Mgmt**|||**Depn**|||**Total**|Total|
|||£|£|£|£|£|£|£|£|£|
||Fundraising|31,825|40,873|47,975|27,380|118,444|15,577|16,726|298,800|286,251|
||Commercial trading|104,702|134,471|157,835|90,080|389,675|51,248|55,027|983,038|811,859|
||Lottery|2,307|2,963|3,478|1,985|8,586|1,129|1,212|21,660|18,656|
||Inpatient Unit|66,977|86,020|100,966|57,623|249,271|32,783|35,200|628,840|614,761|
||Day Services|6,270|8,053|9,452|5,395|23,336|3,069|3,295|58,870|94,025|
||Community|78,060|100,255|117,674|67,159|290,521|38,208|41,025|732,902|573,625|
||Therapies and|33,990|43,656|51,241|29,244|126,507|16,638|17,864|319,140|222,026|
||Wellbeing||||||||||
|||324,131|416,291|488,621|278,866|1,206,340|158,652|170,349|3,043,250|2,621,203|



## 

|Group and Charity||||||
|---|---|---|---|---|---|
||**Freehold**|**Lease**|**Equipment,**|||
||**land and**|**property**|**fixtures and**|**Motor**||
||**buildings**||**fittings**|**Vehicles**|**Total**|
||£|£|£|£|£|
|**Cost**||||||
|At 1 April 2021|6,704,231||2,424,598|22,845|9,151,674|
|Additions||17,000|167,342||184,342|
|Disposals|||(99,092)||(99,092)|
|**At 31 March 2022**|**6,704,231**|**17,000**|**2,492,848**|**22,845**|**9,236,924**|
|**Depreciation**||||||
|At 1 April 2021|1,665,696||1,739,143|22,845|3,427,684|
|Charge for the year|174,346|2,429|420,316||597,091|
|Eliminated on disposal|||(99,092)||(99,092)|
|**At 31 March 2022**|**1,840,042**|**2,429**|**2,060,367**|**22,845**|**3,925,683**|
|**Net written down value**||||||
|**At 31 March 2022**|**4,864,189**|**14,571**|**432,481**||**5,311,241**|
|At 31 March 2021|5,038,535||685,455||5,723,990|





## 

## 

## 

|Charity||||||
|---|---|---|---|---|---|
||**Freehold**|**Lease**|**Equipment,**|||
||**land and**|**property**|**fixtures and**|**Motor**||
||**buildings**||**fittings**|**Vehicles**|**Total**|
||£|£|£|£|£|
|**Cost**||||||
|At 1 April 2021|6,704,231||2,424,598|22,845|9,151,674|
|Additions||17,000|151,256||168,256|
|Disposals|||(99,092)||(99,092)|
|**At 31 March 2022**|**6,704,231**|**17,000**|**2,476,762**|**22,845**|**9,220,838**|
|**Depreciation**||||||
|**At** 1 April 2021|1,665,696||1,739,143|22,845|3,427,684|
|Charge for the year|174,346|2,429|418,018||594,793|
|Eliminated on disposal|||(99,092)||(99,092)|
|**At 31 March 2022**|**1,840,042**|**2,429**|**2,058,069**|**22,845**|**3,923,385**|
|**Net written down value**||||||
|**At 31 March 2022**|**4,864,189**|**14,571**|**418,693**||**5,297,453**|
|At 31 March 2021|5,038,535||685,455||5,723,990|
|**10.2 Intangible fixed assets**||||||
|Group and Charity||||||



||**Goodwill**|**Software**|**Total**|
|---|---|---|---|
||£|£|£|
|**Cost**||||
|At 1 April 2021||180,642|180,642|
|Additions|36,000|25,834|61,834|
|Disposals||(36,550)|(36,550)|
|**At 31 March 2022**|**36,000**|**169,926**|**205,926**|
|**Amortisation**||||
|At 1 April 2021||34,027|34,027|
|Charge for the year||33,642|33,642|
|Impairment loss|36,000||36,000|
|**At 31 March 2022**|**36,000**|**67,669**|**103,669**|
|**Net written down value**||||
|**At 31 March 2022**||**102,257**|**102,257**|
|At 31 March 2021||146,615|146,615|





|Charity||
|---|---|
||**Software**|
||£|
|**Cost**||
|At 1 April 2021|180,642|
|Additions|25,834|
|Disposals|(36,550)|
|**At 31 March 2022**|**169,926**|
|**Amortisation**||
|At 1 April 2021|34,027|
|Chargeforthe year|33,642|
|**At 31 March 2022**|**67,669**|
|**Net written down value**||
|**At 31 March 2022**|**102,257**|
|At 31 March 2021|146,615|





## 

||||**Group**||**Charity**|
|---|---|---|---|---|---|
|||**2022**|2021|**2022**|2021|
|||£|£|£|£|
|Investments in subsidiary undertakings||||**30,000**|30,000|
|Long term|investments|**6,156,108**|5,537,351|**6,156,108**|5,537,351|
|||**6,156,108**|5,537,351|**6,186,108**|5,567,351|



## 

||**Group and charity**|**Group and charity**|
|---|---|---|
||**2022**|2021|
||£|£|
|**Market value**|||
|At 1 April 2021|**5,537,339**|4,555,657|
|Additions|**505,560**|16,310|
|Disposals|||
|Realised gains|||
|Unrealised gains/(losses)|**113,186**|965,372|
||**6,156,085**|5,537,339|
|Cash deposits|**13**|2|
|Hospice Quality Partnership|**10**|10|
|**At 31 March 2022**|**6,156,108**|5,537,351|
|_Market value can be analysed as follows:_|||
|UK listed equities and unit trusts|**6,156,085**|5,537,339|
|Cash deposits|**13**|2|
|Hospice Quality Partnership|**10**|10|
||**6,156,108**|5,537,351|
|_The historical cost of long term investments can be analysed_|||
|_as follows:_|||
|UK listed equities and unit trusts|**3,186,208**|2,680,648|
|Cash deposits|**13**|2|
|Hospice Quality Partnership|**10**|10|
|**Cost at 31 March 2022**|**3,186,231**|2,680,660|





## 

## 

||**2022**|2021|
|---|---|---|
||£|£|
|Turnover|**398,883**|111,920|
|Costofsales|**(308,312)**|(110,734)|
|Gross profit|**90,571**|1,186|
|Administrative expenses|**(194,990)**|(102,721)|
|Operating (loss)/profit|**(104,419)**|(101,535)|
|Tax on (loss)/profit|**60,866**|(866)|
|(Loss)/profit after tax and profit forthe year|**(43,553)**|(102,401)|
|**Balance Sheet**|||
||**2022**|2021|
||£|£|
|Fixed assets|**13,788**||
|Current assets|**146,898**|66,057|
|Creditors: amounts falling due within one year|**(259,051)**|(120,869)|
|Total net (liabilities)/assets|**(98,365)**|(54,812)|
|Share capital|**20,000**|20,000|
|Reserves|**(118,365)**|(74,812)|
||**(98,365)**|(54,812)|





||**2022**|2021|
|---|---|---|
||£|£|
|Turnover|**741,983**|696,900|
|Cost ofsales|**(448,167)**|(443,452)|
|Gross profit|**293,816**|253,448|
|Administrative expenses|**(194,289)**|(194,505)|
|Grants receivable|**6,200**|21,390|
|Operating profit|**105,727**|80,333|
|Tax on profit|**(60,000)**||
|Profit aftertax and forthe year|**45,727**|80,333|
|**Balance Sheet**|||
||**2022**|2021|
||£|£|
|Currentassets|**119,354**|81,348|
|Creditors: amounts falling due within one year|**(109,035)**|(48,815)|
|Total net assets/(liabilities)|**10,319**|32,533|
|Share capital|**10,000**|10,000|
|Reserves|**319**|22,533|
||**10,319**|32,533|



|||||||||**Group**|**Charity**||
|---|---|---|---|---|---|---|---|---|---|---|
||||||||**2022**|2021|**2022**|2021|
||||||||£|£|£|£|
|Bought|in|goods|for|resale|and|consumables|**91,792**|72,611|**5,760**|6,554|



|**tors**|||||
|---|---|---|---|---|
|||**Group**|**Charity**||
||**2022**|2021|**2022**|2021|
||£|£|£|£|
|Trade debtors|**2,303,015**|346,603|**2,206,496**|273,583|
|Other debtors|**98,254**|48,941|**97,389**|48,942|
|Amount due from group undertakings|||**253,197**|95,519|
|Prepayments and accrued income|**9,716,589**|2,220,620|**9,716,589**|2,218,174|
||**12,117,858**|2,616,164|**12,273,671**|2,636,218|





## 

||||**Group**|**Charity**|**Charity**|
|---|---|---|---|---|---|
|||**2022**|2021|**2022**|2021|
|||£|£|£|£|
|Cash|at bank|**7,661,833**|4,394,011|**7,647,573**|4,392,252|
|Petty|cash|**2,120**|3,236|**2,020**|3,136|
|||**7,663,953**|4,397,247|**7,649,593**|4,395,388|



||**Group**||**Charity**||
|---|---|---|---|---|
||**2022**|2021|**2022**|2021|
||£|£|£|£|
|Trade creditors|**167,665**|139,245|**167,665**|139,245|
|Taxation and social security costs|**193,618**|152,584|**193,618**|152,584|
|Other creditors|**356,406**|94,703|**353,004**|91,303|
|Amountdue to group undertakings|||**8,475**|4,024|
|Accruals|**649,128**|571,399|**597,640**|500,634|
|Deferred income|**3,833,987**|1,091,062|**3,833,987**|1,091,062|
||**5,200,804**|2,048,993|**5,154,389**|1,978,852|
|**Deferred income**|||||
|Balance at 1 April|**1,091,062**|250,754|**1,091,062**|250,754|
|Additional amounts of income deferred|**3,703,019**|1,476,273|**3,703,019**|1,476,273|
|Amount released to income|**(960,094)**|(635,965)|**(960,094)**|(635,965)|
|Balance at 31 March|**3,833,987**|1,091,062|**3,833,987**|1,091,062|



||**Group**||**Charity**||
|---|---|---|---|---|
||**2022**|2021|**2022**|2021|
||£|£|£|£|
|Balance at 1 April 2021|||||
|Provision made in the year|**38,122**||**38,122**||
|Balance at 31 March 2022|**38,122**||**38,122**||





## 

## 

|||||**Fixed**|**Investments**|**Other **|**net**|**net**||**Total**|**Total**||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|||||**assets**||**assets**|||||||
|||||£|£||£||||£||
|**General fund (unrestricted)**|||||2,956,108|38,196|||**2,994,304**||||
|**Designated funds (unrestricted)**|||||||||||||
|Fixed assets fund||||5,413,498|||||**5,413,498**||||
|Building refurbishment fund|||||3,200,000|300,000|||**3,500,000**||||
|Patient services projects fund||||||2,420,000|||**2,420,000**||||
|Future deficit offset||||||1,700,000|||**1,700,000**||||
|Legacies deferral fund||||||1,177,000|||**1,177,000**||||
|Major legacy received in 2022||||||7,650,000|||**7,650,000**||||
|Out of hospital project with|ESNEFT|||||690,000||||**690,000**|||
|Energy efficiency and carbon||neutral||||500,000||||**500,000**|||
|investments|||||||||||||
|||||5,413,498|6,156,108|14,475,196|||**26,044,802**||||
|**Restricted fund**||||||165,781||||**165,781**|||
|||||5,413,498|6,156,108|14,640,977|||**26,210,583**||||
||**Balance **||**at**|**Income**|**Expenditure**|**Transfers**||**Investment**|||**Balance **|**at**|
|||**1 April**|||||||**Gains**||**31 March**||
|||**2021**|||||||||**2022**||
||||£|£|£|£|||£|||£|
|**General fund (unrestricted)**||7,194,851||21,385,664|(11,646,388)|(14,053,009)|||113,186||**2,994,304**||
|**Designated funds**|||||||||||||
|**(unrestricted)**|||||||||||||
|Fixed assets fund||5,870,605||||(457,107)|||||**5,413,498**||
|Building refurbishment fund||500,000||||3,000,000|||||**3,500,000**||
|Patient services fund||1,064,884||||1,355,116|||||**2,420,000**||
|Retail lock down fund||550,000||||(550,000)|||||||
|Future deficit offset||||||1,700,000|||||**1,700,000**||
|Legacies deferral fund||1,012,000||||165,000|||||**1,177,000**||
|Major legacy in 2022||||||7,650,000|||||**7,650,000**||
|Out of hospital<br>project with|||||||||||||
|ESNEFT||||||690,000|||||**690,000**||
|Energy efficiency and carbon|||||||||||||
|neutural investment||||||500,000|||||**500,000**||
|**Total unrestricted funds**||16,192,340||21,385,664|(11,646,388)||||113,186||**26,044,802**||
|**Restricted funds**|||||||||||||
|Hospice UK||||1,677,421|(1,677,421)||||||||
|Various||252,645||177,630|(264,494)||||||**165,781**||
|||16,444,985||23,240,715|(13,588,303)||||113,186||**26,210,583**||





## 

||||**Fixed**|**Investments**|**Investments**|**Other **|**net**|**Total**|**Total**||
|---|---|---|---|---|---|---|---|---|---|---|
||||**assets**|||**assets**|||||
||||£|£|||£||£||
|**General fund (unrestricted)**||||5,537,351||1,657,500||**7,194,851**|||
|**Designated funds (unrestricted)**|||||||||||
|Fixed assets fund|||5,870,605|||||**5,870,605**|||
|Building refurbishment fund||||||500,000||**500,000**|||
|Patient services fund||||||1,000,000||**1,000,000**|||
|Retail lock down fund||||||550,000||**550,000**|||
|Legacies deferral fund||||||1,012,000||**1,012,000**|||
|Service development fund||||||64,884|||**64,884**||
||||5,870,605|5,537,351||4,784,384||**16,192,340**|||
|**Restricted fund**||||||252,645||**252,645**|||
||||5,870,605|5,537,351||5,037,029||**16,444,985**|||
||**Balance **|**at**|**Income**|**Expenditure**||**Transfers**|**Investment**||**Balance **|**at**|
||**1 April**|||||||**Gains**|**31 March**||
||**2020**||||||||**2021**||
|||£|£|£||£||£||£|
|**General fund (unrestricted)**|6,909,577||11,892,819|(9,777,393)|(2,795,524)|||965,372|**7,194,851**||
|**Designated funds**|||||||||||
|**(unrestricted)**|||||||||||
|Fixed assets fund|6,137,081|||||(266,476)|||**5,870,605**||
|Building refurbishment|||||||||||
|fund||||||500,000|||**500,000**||
|Patient services fund||||||1,000,000|||**1,000,000**||
|Retail lock down fund||||||550,000|||**550,000**||
|Legacies deferral fund||||||1,012,000|||**1,012,000**||
|Service development fund|64,884||||||||**64,884**||
|**Total unrestricted funds**|13,111,542||11,892,819|(9,777,393)||||965,372|**16,192,340**||
|**Restricted funds**|||||||||||
|Various|81,809||2,989,11 O|(2,818,274)|||||**252,645**||
||13,193,351||14,881,929|(12,595,667)||||965,372|**16,444,985**||





## 

## 

||**Fixed**|**Investments**|**Other net**|**Total**|
|---|---|---|---|---|
||**assets**||**assets**||
||£|£|£|£|
|**General fund (unrestricted)**||2,986,108|140,032|**3,126,140**|
|**Designated funds (unrestricted)**|||||
|Fixed assets fund|5,399,710|||**5,399,710**|
|Building refurbishment fund||3,200,000|300,000|**3,500,000**|
|Patient services projects fund|||2,420,000|**2,420,000**|
|Future deficit offset|||1,700,000|**1,700,000**|
|Legacies deferral fund|||1,177,000|**1,177,000**|
|Major legacy in 2022|||7,650,000|**7,650,000**|
|Out of hospital project with ESNEFT|||690,000|**690,000**|
|Energy efficiency & carbon neutral investment|||500,000|**500,000**|
||5,399,710|6,186,108|14,577,032|**26,162,850**|
|**Restricted fund**|||165,781|**165,781**|
||5,399,710|6,186,108|14,742,813|**26,328,631**|



||**Balance at**|**Income**|**Expenditure**|**Transfers**|**Investment**|**Balance at**|
|---|---|---|---|---|---|---|
||**1 April**||||**Gains**|**31 March**|
||**2021**|||||**2022**|
||£|£|£|£|£|£|
|**General fund (unrestricted)**|7,247,130|20,613,135|(10,808,090)|(14,039,221)|113,186|**3,126,140**|
|**Designated funds (unrestricted)**|||||||
|Fixed assets fund|5,870,605|||(470,895)||**5,399,710**|
|Building refurbishmentfund|500,000|||3,000,000||**3,500,000**|
|Patientservices fund|1,064,884|||1,355,116||**2,420,000**|
|Retail lock downfund|550,000|||(550,000)|||
|Future deficitoffset fund||||1,700,000||**1,700,000**|
|Legacies deferral fund|1,012,000|||165,000||**1,177,000**|
|Major legacy in 2022||||7,650,000||**7,650,000**|
|Out of hospital projectwith ESNEFT||||690,000||**690,000**|
|Energy efficiency & carbon neutral|||||||
|investment||||500,000||**500,000**|
|**Total unrestricted funds**|16,244,619|20,613,135|(10,808,090)||113,186|**26,162,850**|
|**Restricted funds**|||||||
|Hospice UK||1,677,421|(1,677,421)||||
|Various|252,645|177,630|(264,494)|||**165,781**|
|Total Restrictedfunds|252,645|1,855,051|(1,941,915)|||165,781|
||16,497.,264|22,468,186|(12,750,005)||113,186|**26,328,631**|



## 

## 



## 



## 

## 

||||**Fixed**|**Investments**|**Investments**|**Net Current**|**Net Current**|**Total**|**Total**|
|---|---|---|---|---|---|---|---|---|---|
||||**assets**|||**Assets**||||
||||£|£|||£||£|
|**General fund (unrestricted)**||||5,567,351||1,679,779||**7,247,130**||
|**Designated funds (unrestricted)**||||||||||
|Fixed assets fund|||5,870,605|||||**5,870,605**||
|Building refurbishment fund||||||500,000||**500,000**||
|Patient services fund||||||1,000,000||**1,000,000**||
|Retail lock down fund||||||550,000||**550,000**||
|Legacies deferral fund||||||1,012,000||**1,012,000**||
|Service development fund||||||64,884|||**64,884**|
||||5,870,605|5,567,351||4,806,663||**16,244,619**||
|**Restricted fund**||||||252,645||**252,645**||
||||5,870,605|5,567,351||5,057,308||**16,497,264**||
||**Balance **|**at**|**Income**|**Expenditure**|**Transfers**||**Investment**||**Balance at**|
||**1 April**||||||**Gains**||**31 March**|
||**2021**||||||||**2022**|
|||£|£|£||£||£|£|
|**General fund (unrestricted)**|6,939,788||11,205,727|(9,068,233)|(2,795,524)|||965,372|**7,247,130**|
|**Designated funds (unrestricted)**||||||||||
|Fixed assets fund|6,137,081|||||(266,476)||-|**5,870,605**|
|Building refurbishment fund||||||500,000|||**500,000**|
|Patient services fund||||-||1,000,000||-|**1,000,000**|
|Retail lock down fund||||||550,000|||**550,000**|
|Legacies deferral fund||||-||1,012,000||-|**1,012,000**|
|Service development fund|64,884||||||||**64,884**|
|**Total unrestricted funds**|13,141,753||11,205,727|(9,068,233)||||965,372|**16,244,619**|
|**Restricted funds**||||||||||
|Hospice UK||-|2,642,892|(2,642,892)||||||
|Various|81,809||346,218|(175,382)|||||**252,645**|
|Total Restricted funds|81,809||**2,989,110**|**(2,818,274)**|||||**252,645**|
||13,223,562||14,194,837|(11,886,507)||||965,372|**16,497,264**|





## 

## 

|||**Land** &||**Motor**||**Land** &||
|---|---|---|---|---|---|---|---|
||**Equipment**|**buildings**||**Vehicles**|**Equipment**|**buildings**||
||**2022**|**2022**|**2022**|**2021**|**2021**|**2021**|**2021**|
|Operating lease|£|£|£|£|£|£|£|
|obligations:||||||||
|Within one year|**7,425**|**449,642**|**457,067**|**15,963**|**6,900**|**456,367**|**456,367**|
|In one to two|**7,425**|**298,418**|**305,843**||**6,900**|**329,019**|**329,019**|
|years||||||||
|In two to five|**11,351**|**562,570**|**573,921**||**16,675**|**298,365**|**298,365**|
|years||||||||
|Over five years|**88**|**69,125**|**69,213**|||**87,687**|**87,687**|
||**26,289**|**1,379,755**|**1,406,044**|**15,963**|**30,475**|**1,171,438**|**1,171,438**|





## 

||**Land and**|
|---|---|
||**Buildings**|
||**2022**|
|Operating lease|£|
|obligations:||
|Within one year|28,500|
|In one to two years|28,500|
|In two to five years|85,500|
|Over five years|33,250|
||**175,750**|



||**2022**|2021|
|---|---|---|
||£|£|
|Income from related parties:|||
|Income from costs recharged to subsidiary undertakings|**184,346**|127,486|
|Gift aid from subsidiaries|**67,941**||
|Donations from Trustees|**269**|253|
|Costs from related parties|**93,750**|11,709|
|Balance due from subsidiary undertaking at 31 March|**253,197**|95,519|
|Balance due to subsidiary undertakings at 31 March|**8,475**|4,024|



## 

|||||||||**Group**|**Charity**|**Charity**|
|---|---|---|---|---|---|---|---|---|---|---|
||||||||**2022**|2021|**2022**|2021|
||||||||£|£|£|£|
|Instruments|measured|at|fair|value|through|SOFA|**6,156,095**|5,537,349|**6,156,095**|5,537,349|





## 

## 

||**Initial **|**Book Value**|**Fair value adjustment**|**Initial **|**Book Value**|
|---|---|---|---|---|---|
|Fixed assets||**35,000**|**(18,000)**||17,000|
|Stock||**968**|||968|
|**Net assets**||**35,968**|**(18,000)**||**17,968**|
|Goodwill|||||36,000|
|**Total Consideration**|||||**53,968**|





##